Blair William & Co. IL Reduces Stake in Phreesia, Inc. (NYSE:PHR)

Key Points

• Blair William & Co. IL decreased its stake in Phreesia, Inc. by 14.5%, selling 21,044 shares and retaining 124,406 shares valued at $3.18 million.
• A number of hedge funds have increased their positions in Phreesia, with one firm reporting a 381.3% increase in its holdings.
• Analyst ratings for Phreesia are generally positive, with a consensus rating of "Buy" and an average price target of $32.27.

Blair William & Co. IL lowered its position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 14.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 124,406 shares of the company's stock after selling 21,044 shares during the quarter. Blair William & Co. IL owned about 0.21% of Phreesia worth $3,180,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Johnson Financial Group Inc. increased its position in Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after acquiring an additional 896 shares during the period. Quarry LP boosted its stake in Phreesia by 210.9% during the 4th quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after purchasing an additional 1,923 shares in the last quarter. KBC Group NV acquired a new position in shares of Phreesia in the 1st quarter worth $74,000. CWM LLC grew its holdings in shares of Phreesia by 994.9% in the 1st quarter. CWM LLC now owns 4,040 shares of the company's stock worth $103,000 after acquiring an additional 3,671 shares during the last quarter. Finally, NewEdge Advisors LLC boosted its position in shares of Phreesia by 12.1% in the fourth quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock worth $107,000 after buying an additional 459 shares during the period. Institutional investors and hedge funds own 92.10% of the company's stock.

Phreesia Stock Up 0.6%

NYSE PHR traded up $0.16 on Friday, reaching $27.00. The company had a trading volume of 388,293 shares, compared to its average volume of 495,033. The firm has a market capitalization of $1.61 billion, a price-to-earnings ratio of -36.49 and a beta of 0.71. The company has a debt-to-equity ratio of 0.02, a quick ratio of 1.95 and a current ratio of 1.95. Phreesia, Inc. has a 1-year low of $17.07 and a 1-year high of $30.53. The company's fifty day moving average is $27.10 and its 200-day moving average is $26.40.

Phreesia (NYSE:PHR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative net margin of 9.83% and a negative return on equity of 16.23%. The company had revenue of $115.94 million during the quarter, compared to the consensus estimate of $115.00 million. During the same period in the prior year, the business posted ($0.05) EPS. The company's quarterly revenue was up 14.5% on a year-over-year basis. On average, research analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

PHR has been the subject of several recent research reports. KeyCorp increased their price objective on Phreesia from $28.00 to $35.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Truist Financial increased their price objective on Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, May 29th. Citigroup reiterated a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Finally, DA Davidson upgraded Phreesia to a "strong-buy" rating in a report on Tuesday, July 22nd. Eleven investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Phreesia has an average rating of "Buy" and a consensus price target of $32.27.

Insider Transactions at Phreesia

In other news, COO Evan Roberts sold 1,892 shares of Phreesia stock in a transaction on Thursday, July 17th. The shares were sold at an average price of $26.89, for a total transaction of $50,875.88. Following the transaction, the chief operating officer owned 772,915 shares in the company, valued at approximately $20,783,684.35. The trade was a 0.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Lisa Egbuonu-Davis sold 2,802 shares of Phreesia stock in a transaction on Thursday, June 26th. The stock was sold at an average price of $27.67, for a total transaction of $77,531.34. Following the transaction, the director owned 22,037 shares in the company, valued at approximately $609,763.79. This trade represents a 11.28% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 53,804 shares of company stock worth $1,510,733. 5.50% of the stock is currently owned by insiders.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.